Breathe Well Live Well
|
FDA Approves Pharmaxis' ARIDOL™ (Mannitol Inhalation Powder) Bronchial …
Kansas City Star ARIDOL is used for the assessment of bronchial hyperresponsiveness in patients six years of age and older who do not have clinically apparent asthma. … |
View full post on asthma – Google News
Condition: Asthma
Interventions: Drug: Fluticasone Furoate/GW642444; Drug: Fluticasone propionate
Sponsor: GlaxoSmithKline
Active, not recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Condition: Asthma
Interventions: Drug: Fluticasone propionate inhalation powder; Drug: Fluticasone furoate inhalation powder; Drug: Placebo inhalation powder
Sponsor: GlaxoSmithKline
Recruiting – verified October 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days
Condition: Asthma
Interventions: Drug: Budesonide; Drug: Budesonide; Drug: Budesonide
Sponsor: Activaero GmbH
Recruiting – verified September 2010
View full post on ClinicalTrials.gov: “Asthma” | updated in the last 30 days